🇺🇸 Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
Recall date: December 18, 2025Country: USCategory: consumer_productsBrand: MiramarLab, of Doral, Florida Hazard/Reason: The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
This page links to official sources. Verify model/lot/batch details in the official notice.